Company profile for NanoViricides

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in class drugs against viruses. A nanoviricide is designed to specifically attack enveloped virus particles, on the same sites that they use to bind to cells, and dismantle them, blocking reinfection cycle, going beyond what antibodies and immun...
NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in class drugs against viruses. A nanoviricide is designed to specifically attack enveloped virus particles, on the same sites that they use to bind to cells, and dismantle them, blocking reinfection cycle, going beyond what antibodies and immunotherapeutics do. A nanoviricide can also be designed to deliver anti-viral payload into infected cells sparing uninfected cells to block replication cycle without toxicity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1 Controls Drive, Shelton, CT 06484
Telephone
Telephone
+1-203-937-6137
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-01/nanoviricides-has-signed-a-master-services-agreement-with-onlyorphanscote-regarding-orphan-drug-stra

PHARMIWEB
01 Dec 2025

https://www.pharmiweb.com/press-release/2025-11-17/nanoviricides-inc-has-filed-its-quarterly-report-subsequent-raise-has-fortified-fiscal-position

PHARMIWEB
17 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-14/nanoviricides-to-present-at-the-pharma-partnering-summit-2025-in-boston-today-november-14th-nv-38

PHARMIWEB
14 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-12/nanoviricides-announces-closing-of-6-million-registered-direct-offering-and-concurrent-private-plac

PHARMIWEB
12 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-11/nanoviricides-announces-pricing-of-6-million-registered-direct-offering-and-concurrent-private-plac

PHARMIWEB
11 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-10/nanoviricides-has-received-approval-to-start-phase-ii-clinical-trial-of-nv-387-for-the-treatment-of

PHARMIWEB
10 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty